CX5

piperidin-1-yl(quinoxalin-6-yl)methanone

Find entries where: CX5

is present as a standalone ligand in 1 entries

Find related ligands:

Chemical Component Summary
Name	piperidin-1-yl(quinoxalin-6-yl)methanone
Identifiers	piperidin-1-yl(quinoxalin-6-yl)methanone
Formula	C₁₄ H₁₅ N₃ O
Molecular Weight	241.288
Type	NON-POLYMER
Isomeric SMILES	c1cc2c(cc1C(=O)N3CCCCC3)nccn2
InChI	InChI=1S/C14H15N3O/c18-14(17-8-2-1-3-9-17)11-4-5-12-13(10-11)16-7-6-15-12/h4-7,10H,1-3,8-9H2
InChIKey	ANDGGVOPIJEHOF-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	33
Chiral Atom Count	0
Bond Count	35
Aromatic Bond Count	11

Drug Info: DrugBank

DrugBank ID	DB06247
Name	CX516
Groups	investigational
Synonyms	CX516
Indication	Investigated for use/treatment in alzheimer's disease, memory loss, autism, neurologic disorders, dementia, schizophrenia and schizoaffective disorders, attention deficit/hyperactivity disorder (ADHD), and sleep disorders.
Categories	Receptors, AMPA
CAS number	154235-83-3

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Glutamate receptor 1	MQHIFAFFCTGFLGAVVGANFPNNIQIGGLFPNQQSQEHAAFRFALSQLT...	unknown

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682